StockData
Acumen Pharmaceuticals, Inc. logo

Acumen Pharmaceuticals, Inc. (ABOS) stock

ABOSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 2/30
$0.19−0.01 (-3.52%)

Close on Nov 20, 2026Market cap $13.49MP/E –Yield –

Acumen Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Acumen Pharmaceuticals

Acumen Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Acumen Pharmaceuticals figures

See a number that looks wrong?